Alladapt Immunotherapeutics

Getty Image picture of peanut butter and nuts to show allergy

Biotech

Alladapt's 15-allergen drug desensitizes kids to multiple foods

The phase 1/2 trial reported dose-dependent changes in recipients of the multi-allergen candidate, encouraging Alladapt to plot a late-stage program.

Nick Paul Taylor Jun 13, 2023 8:15am

Getty Image picture of peanut butter and nuts to show allergy

Alladapt banks $119M to push allergy therapy through trials

Jun 22, 2022 11:35am